...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: link is up

Fuzzy not a bad deal for 20 cents US. What did you expect to hear from Don?

http://118009.choruscall.com/zenithepigenetics/zenith20221027.pdf

 

Koo

Share
New Message
Please login to post a reply